Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Cytotoxic | 4 | 2022 | 174 | 1.500 |
Why?
|
| Cell Surface Display Techniques | 3 | 2025 | 6 | 1.390 |
Why?
|
| Antigens, Neoplasm | 5 | 2025 | 137 | 1.210 |
Why?
|
| Intubation, Intratracheal | 7 | 2013 | 202 | 1.110 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2025 | 96 | 1.050 |
Why?
|
| Antigens, CD | 4 | 2021 | 348 | 1.000 |
Why?
|
| GPI-Linked Proteins | 1 | 2025 | 41 | 0.940 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2025 | 287 | 0.830 |
Why?
|
| T-Lymphocytes | 2 | 2025 | 1005 | 0.780 |
Why?
|
| Single-Chain Antibodies | 4 | 2022 | 7 | 0.720 |
Why?
|
| Neoplasms | 5 | 2025 | 1350 | 0.640 |
Why?
|
| Analgesia, Epidural | 6 | 2002 | 28 | 0.640 |
Why?
|
| Analgesia, Obstetrical | 6 | 2002 | 23 | 0.640 |
Why?
|
| Antibodies | 1 | 2019 | 182 | 0.610 |
Why?
|
| Anesthesia, Spinal | 4 | 2011 | 30 | 0.590 |
Why?
|
| Needles | 3 | 2011 | 66 | 0.560 |
Why?
|
| Fentanyl | 7 | 2002 | 75 | 0.540 |
Why?
|
| Cell Line, Tumor | 6 | 2025 | 1451 | 0.520 |
Why?
|
| Anesthesia, Obstetrical | 4 | 2001 | 24 | 0.490 |
Why?
|
| Peptide Library | 6 | 2025 | 36 | 0.480 |
Why?
|
| Mutagenesis | 1 | 2015 | 131 | 0.480 |
Why?
|
| Chemokines | 1 | 2015 | 95 | 0.480 |
Why?
|
| Molecular Biology | 1 | 2015 | 67 | 0.470 |
Why?
|
| Bupivacaine | 4 | 2008 | 35 | 0.450 |
Why?
|
| Anesthesia, Epidural | 4 | 2001 | 24 | 0.450 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2025 | 189 | 0.440 |
Why?
|
| Complementarity Determining Regions | 5 | 2020 | 38 | 0.440 |
Why?
|
| Bronchoscopes | 2 | 2006 | 10 | 0.430 |
Why?
|
| Inhalation | 1 | 2013 | 11 | 0.430 |
Why?
|
| Respiratory Sounds | 1 | 2013 | 21 | 0.430 |
Why?
|
| Anesthetics, Local | 3 | 2008 | 71 | 0.390 |
Why?
|
| Infant, Premature | 1 | 2013 | 183 | 0.370 |
Why?
|
| Labor, Obstetric | 4 | 2000 | 38 | 0.360 |
Why?
|
| Humans | 44 | 2025 | 62682 | 0.320 |
Why?
|
| Analgesics, Opioid | 4 | 2002 | 533 | 0.310 |
Why?
|
| Anesthesiology | 2 | 2006 | 41 | 0.280 |
Why?
|
| Peptides | 3 | 2008 | 574 | 0.260 |
Why?
|
| Amino Acid Sequence | 7 | 2019 | 1594 | 0.250 |
Why?
|
| Fiber Optic Technology | 2 | 2006 | 24 | 0.240 |
Why?
|
| Protein Binding | 7 | 2021 | 1601 | 0.240 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2015 | 495 | 0.230 |
Why?
|
| Laryngeal Masks | 1 | 2004 | 26 | 0.220 |
Why?
|
| Sufentanil | 4 | 2000 | 8 | 0.220 |
Why?
|
| Antigens | 2 | 2019 | 147 | 0.210 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 58 | 0.210 |
Why?
|
| Ligands | 4 | 2015 | 417 | 0.210 |
Why?
|
| High-Throughput Screening Assays | 1 | 2024 | 78 | 0.210 |
Why?
|
| Machine Learning | 1 | 2025 | 175 | 0.210 |
Why?
|
| Solubility | 2 | 2021 | 179 | 0.200 |
Why?
|
| Mice | 5 | 2025 | 10804 | 0.200 |
Why?
|
| Primary Cell Culture | 1 | 2022 | 78 | 0.190 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2001 | 4 | 0.190 |
Why?
|
| Labor Stage, First | 1 | 2001 | 7 | 0.190 |
Why?
|
| Escherichia coli | 4 | 2024 | 708 | 0.190 |
Why?
|
| Healthy Volunteers | 1 | 2022 | 76 | 0.190 |
Why?
|
| Female | 17 | 2025 | 32495 | 0.190 |
Why?
|
| Cesarean Section | 2 | 2000 | 98 | 0.190 |
Why?
|
| Gene Library | 1 | 2022 | 102 | 0.180 |
Why?
|
| HEK293 Cells | 2 | 2022 | 618 | 0.180 |
Why?
|
| Clone Cells | 1 | 2021 | 114 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2004 | 295 | 0.180 |
Why?
|
| Binding Sites | 4 | 2015 | 900 | 0.180 |
Why?
|
| Radioimmunotherapy | 1 | 2020 | 7 | 0.180 |
Why?
|
| Lidocaine | 2 | 1998 | 33 | 0.180 |
Why?
|
| Equipment Failure | 4 | 2011 | 65 | 0.180 |
Why?
|
| Epinephrine | 2 | 1998 | 44 | 0.180 |
Why?
|
| Crystallography, X-Ray | 4 | 2014 | 431 | 0.180 |
Why?
|
| Protein Multimerization | 1 | 2021 | 174 | 0.170 |
Why?
|
| Immunoconjugates | 1 | 2020 | 89 | 0.170 |
Why?
|
| Spinal Puncture | 1 | 2000 | 15 | 0.170 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 25 | 0.170 |
Why?
|
| Cervix Uteri | 1 | 2000 | 56 | 0.170 |
Why?
|
| Headache | 1 | 2000 | 58 | 0.160 |
Why?
|
| Tyrosine | 1 | 2000 | 93 | 0.160 |
Why?
|
| Animals | 7 | 2025 | 20584 | 0.160 |
Why?
|
| Cell Line | 3 | 2019 | 2038 | 0.160 |
Why?
|
| Immunotherapy | 2 | 2019 | 250 | 0.160 |
Why?
|
| Protein Domains | 1 | 2019 | 148 | 0.150 |
Why?
|
| Alanine | 2 | 2015 | 51 | 0.150 |
Why?
|
| Major Histocompatibility Complex | 3 | 2011 | 88 | 0.150 |
Why?
|
| Epitopes | 1 | 2019 | 295 | 0.150 |
Why?
|
| Pregnancy | 9 | 2002 | 2318 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 453 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2020 | 476 | 0.140 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2017 | 4 | 0.140 |
Why?
|
| Anesthesia, Closed-Circuit | 1 | 1997 | 2 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2012 | 671 | 0.140 |
Why?
|
| Sacrum | 2 | 2008 | 25 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2004 | 787 | 0.130 |
Why?
|
| Genetic Loci | 1 | 2017 | 118 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 1997 | 90 | 0.130 |
Why?
|
| Rhizobium leguminosarum | 1 | 1996 | 1 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2008 | 119 | 0.130 |
Why?
|
| Acetyltransferases | 1 | 1996 | 27 | 0.130 |
Why?
|
| Mandibular Diseases | 1 | 1995 | 2 | 0.120 |
Why?
|
| Alveolar Bone Loss | 1 | 1995 | 5 | 0.120 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1995 | 48 | 0.120 |
Why?
|
| Cloning, Molecular | 1 | 2015 | 383 | 0.120 |
Why?
|
| Chemokines, CC | 1 | 2014 | 13 | 0.120 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 363 | 0.120 |
Why?
|
| Receptors, Chemokine | 1 | 2014 | 33 | 0.110 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2012 | 148 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2014 | 1992 | 0.110 |
Why?
|
| Surface Plasmon Resonance | 3 | 2014 | 34 | 0.110 |
Why?
|
| Lymphocyte Activation | 3 | 2012 | 759 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2008 | 641 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 670 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2012 | 77 | 0.100 |
Why?
|
| Double-Blind Method | 5 | 2002 | 739 | 0.090 |
Why?
|
| Pain Measurement | 4 | 2002 | 343 | 0.090 |
Why?
|
| Pain, Postoperative | 2 | 2008 | 161 | 0.090 |
Why?
|
| Kinetics | 3 | 2011 | 764 | 0.090 |
Why?
|
| HLA-A2 Antigen | 2 | 2008 | 64 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2014 | 247 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2015 | 705 | 0.090 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 86 | 0.090 |
Why?
|
| Receptors, Immunologic | 1 | 2011 | 177 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 1996 | 769 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2011 | 104 | 0.080 |
Why?
|
| Nerve Block | 2 | 2008 | 50 | 0.080 |
Why?
|
| Mutation | 4 | 2020 | 2573 | 0.080 |
Why?
|
| Delivery, Obstetric | 1 | 1989 | 51 | 0.080 |
Why?
|
| HLA-A Antigens | 1 | 2008 | 9 | 0.070 |
Why?
|
| CD8 Antigens | 1 | 2008 | 54 | 0.070 |
Why?
|
| Circumcision, Male | 1 | 2008 | 9 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2008 | 25 | 0.070 |
Why?
|
| Hernia, Inguinal | 1 | 2008 | 41 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2020 | 293 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 239 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 364 | 0.070 |
Why?
|
| Anesthesia, Caudal | 1 | 2006 | 9 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 1139 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 700 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 99 | 0.060 |
Why?
|
| Respiratory System | 1 | 2006 | 45 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 104 | 0.060 |
Why?
|
| Trachea | 1 | 2006 | 83 | 0.060 |
Why?
|
| Bronchoscopy | 1 | 2006 | 85 | 0.060 |
Why?
|
| Models, Molecular | 2 | 2007 | 1143 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 2006 | 99 | 0.060 |
Why?
|
| Microchemistry | 1 | 2005 | 1 | 0.060 |
Why?
|
| Antibody Affinity | 1 | 2005 | 19 | 0.060 |
Why?
|
| Directed Molecular Evolution | 1 | 2005 | 10 | 0.060 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2005 | 35 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2006 | 337 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2005 | 112 | 0.060 |
Why?
|
| Protein Engineering | 1 | 2005 | 82 | 0.060 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2025 | 179 | 0.060 |
Why?
|
| Klebsiella pneumoniae | 1 | 2024 | 28 | 0.050 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2024 | 57 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 422 | 0.050 |
Why?
|
| Teaching | 1 | 2004 | 156 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 203 | 0.050 |
Why?
|
| HIV-1 | 1 | 2008 | 716 | 0.050 |
Why?
|
| Hydromorphone | 1 | 2002 | 5 | 0.050 |
Why?
|
| Gravidity | 1 | 2001 | 12 | 0.050 |
Why?
|
| Injections, Spinal | 2 | 1998 | 46 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2020 | 53 | 0.040 |
Why?
|
| Anesthetics, Combined | 1 | 2000 | 4 | 0.040 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2000 | 1 | 0.040 |
Why?
|
| Curriculum | 1 | 2004 | 585 | 0.040 |
Why?
|
| Phenylalanine | 1 | 2000 | 26 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2000 | 68 | 0.040 |
Why?
|
| Dura Mater | 1 | 2000 | 34 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2000 | 45 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2025 | 889 | 0.040 |
Why?
|
| Gastrointestinal Contents | 1 | 1998 | 6 | 0.040 |
Why?
|
| Pneumonia, Aspiration | 1 | 1998 | 17 | 0.040 |
Why?
|
| Adult | 5 | 2002 | 16629 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1998 | 74 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 786 | 0.040 |
Why?
|
| ROC Curve | 1 | 2017 | 277 | 0.030 |
Why?
|
| Coenzyme A | 1 | 1996 | 6 | 0.030 |
Why?
|
| Rats | 1 | 2000 | 1978 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 1996 | 22 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 1997 | 156 | 0.030 |
Why?
|
| Crystallization | 1 | 1996 | 99 | 0.030 |
Why?
|
| Middle Aged | 4 | 2001 | 17365 | 0.030 |
Why?
|
| Radiography, Panoramic | 1 | 1995 | 1 | 0.030 |
Why?
|
| Mandible | 1 | 1995 | 9 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1996 | 298 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 1995 | 76 | 0.030 |
Why?
|
| Rhipicephalus sanguineus | 1 | 2014 | 1 | 0.030 |
Why?
|
| Chemokine CCL3 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Chemokine CCL8 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Immunoglobulin Fragments | 1 | 2014 | 7 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 33 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2014 | 49 | 0.030 |
Why?
|
| Bone Density | 1 | 1995 | 134 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 63 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 138 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 271 | 0.030 |
Why?
|
| Morphine | 1 | 1994 | 58 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1995 | 608 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2154 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2014 | 71 | 0.030 |
Why?
|
| Gene Expression | 1 | 1996 | 837 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 691 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 445 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1638 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 1994 | 257 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1995 | 1110 | 0.020 |
Why?
|
| Leukocyte Immunoglobulin-like Receptor B1 | 1 | 2011 | 1 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2011 | 51 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 519 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2011 | 77 | 0.020 |
Why?
|
| Biological Assay | 1 | 2011 | 58 | 0.020 |
Why?
|
| Risk Factors | 2 | 2017 | 5303 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 129 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 567 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2012 | 290 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 168 | 0.020 |
Why?
|
| Infant | 2 | 2008 | 1602 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2011 | 238 | 0.020 |
Why?
|
| Aged | 3 | 1995 | 14254 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2008 | 63 | 0.020 |
Why?
|
| MART-1 Antigen | 1 | 2008 | 8 | 0.020 |
Why?
|
| Injections | 1 | 2008 | 81 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2007 | 131 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2007 | 107 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2007 | 129 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2174 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2007 | 178 | 0.020 |
Why?
|
| Male | 3 | 2008 | 29487 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 411 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 260 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 283 | 0.020 |
Why?
|
| Adolescent | 2 | 1998 | 6172 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 573 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2007 | 774 | 0.010 |
Why?
|
| United States | 1 | 1997 | 7721 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 245 | 0.010 |
Why?
|
| Child | 2 | 2006 | 4444 | 0.010 |
Why?
|
| Apgar Score | 1 | 2002 | 11 | 0.010 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2002 | 14 | 0.010 |
Why?
|
| Gastric Acidity Determination | 1 | 1998 | 5 | 0.010 |
Why?
|
| Esophageal Diseases | 1 | 1998 | 16 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 1998 | 45 | 0.010 |
Why?
|
| Fasting | 1 | 1998 | 51 | 0.010 |
Why?
|
| Conscious Sedation | 1 | 1998 | 39 | 0.010 |
Why?
|
| Stomach | 1 | 1998 | 85 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1998 | 3258 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1998 | 71 | 0.010 |
Why?
|
| Leg | 1 | 1994 | 87 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2006 | 6533 | 0.010 |
Why?
|
| Elective Surgical Procedures | 1 | 1994 | 117 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1998 | 1937 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 862 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1994 | 1341 | 0.010 |
Why?
|